RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Scott to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications John Scott has written about Drug Evaluation, Preclinical.
John Scott
Connection Strength
0.772
Drug Evaluation, Preclinical
  1. Ahmad S, Hughes MA, Yeh LA, Scott JE. Potential repurposing of known drugs as potent bacterial ?-glucuronidase inhibitors. J Biomol Screen. 2012 Aug; 17(7):957-65.
    View in: PubMed
    Score: 0.356
  2. Williams KP, Scott JE. Enzyme assay design for high-throughput screening. Methods Mol Biol. 2009; 565:107-26.
    View in: PubMed
    Score: 0.283
  3. Ahmad S, St Hilaire VR, Dandepally SR, Johnson GL, Williams AL, Scott JE. Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2). Biochem Biophys Res Commun. 2018 01 29; 496(1):205-211.
    View in: PubMed
    Score: 0.132
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support